Soy Isoflavones Regulate Lipid Metabolism through an AKT/mTORC1 Pathway in Diet-Induced Obesity (DIO) Male Rats

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

(2016) U. Rohde et al.   DIABETES OBESITY & METABOLISM

Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease

(2014) Un Jung et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hypertension and overweight/obesity in Ghanaians and Nigerians living in West Africa and industrialized countries

(2014) Yvonne Commodore-Mensah et al.   JOURNAL OF HYPERTENSION

A Central Role for mTOR in Lipid Homeostasis

(2013) Dudley W. Lamming et al.   Cell Metabolism

Hypoxia-Inducible Factor and Vascular Endothelial Growth Factor Are Targets of Dietary Soy During Acute Stroke in Female Rats

(2013) Yulin Ma et al.   ENDOCRINOLOGY

Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts

(2013) Jin-Ran Chen et al.   FASEB JOURNAL

Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats

(2013) Chao Wu Xiao et al.   Genes and Nutrition

Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America

(2013) Laura R Aballay et al.   NUTRITION REVIEWS

Diet beverages and the risk of obesity, diabetes, and cardiovascular disease: a review of the evidence

(2013) Mark A Pereira   NUTRITION REVIEWS

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Soy isoflavones modulate adipokines and myokines to regulate lipid metabolism in adipose tissue, skeletal muscle and liver of male Huanjiang mini-pigs

(2012) Huansheng Yang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway

(2011) Timothy R. Peterson et al.   CELL

Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1c

(2011) Min Wan et al.   Cell Metabolism

S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver

(2011) KyeongJin Kim et al.   HEPATOLOGY

Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage

(2010) P. Chakrabarti et al.   DIABETES

Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

(2010) Katrin Düvel et al.   MOLECULAR CELL

mTORC1 controls fasting-induced ketogenesis and its modulation by ageing

(2010) Shomit Sengupta et al.   NATURE

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

(2010) Shijie Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

(2008) Jingxiang Huang et al.   BIOCHEMICAL JOURNAL

A review

(2008) Sarah S. Cohen et al.   CANCER

SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth

(2008) Thomas Porstmann et al.   Cell Metabolism

Obesity-Associated Liver Disease

(2008) Giulio Marchesini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM